Evidence map›Paper›PMID 28782224›Full record

ArticleJournal of cellular and molecular medicine2018

Prokineticin 1 is up-regulated by insulin in decidualizing human endometrial stromal cells.

Dorina Ujvari, Ivika Jakson, Cecilia Oldmark, Sanaz Attarha, Twana Alkasalias, Daniel Salamon, Sebastian Gidlöf, Angelica Lindén Hirschberg

Open access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 28 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Cell type and region-specific transcriptional changes in the endometrium of women with RIF identify potential treatment targets.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  6. Article
  7. The Roles of Obesity and ASB4 in Preeclampsia Pathogenesis.International journal of molecular sciences · 2024
    Review
  8. Novel Insights into Prokineticin 1 Role in Pregnancy-related Diseases.International journal of medical sciences · 2024
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Dorina UjvariDepartment of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-4659-9712
Ivika JaksonDepartment of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Cecilia OldmarkDepartment of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Sanaz AttarhaDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Twana AlkasaliasDepartment of Microbiology, Tumour, and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
Daniel SalamonDepartment of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Sebastian GidlöfDepartment of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Angelica Lindén HirschbergDepartment of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Karolinska Institutet · SEKarolinska University Hospital · SEUppsala University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prokineticin 1 (PROK1), a hypoxia-regulated angiogenic factor, has emerged as a crucial regulator of embryo implantation and placentation. Dysregulation of PROK1 has been linked to recurrent pregnancy loss, pre-eclampsia, foetal growth restriction and preterm birth. These pregnancy complications are common in women with obesity and polycystic ovary syndrome, i.e. conditions associated with insulin resistance and compensatory hyperinsulinaemia. We investigated the effect of insulin on PROK1 expression during in vitro decidualization. Endometrial stromal cells were isolated from six healthy, regularly menstruating women and decidualized in vitro. Insulin induced a significant dose-dependent up-regulation of PROK1 on both mRNA and protein level in decidualizing endometrial stromal cells. This up-regulation was mediated by hypoxia-inducible factor 1-alpha (HIF1α) via the phosphatidylinositol 3-kinase (PI3K) pathway. Furthermore, we demonstrated that PROK1 did not affect the viability, but significantly inhibited the migration of endometrial stromal cells and the migratory and invasive capacity of trophoblast cell lines. This in vitro study provides new insights into the regulation of PROK1 by insulin in human decidualizing endometrial stromal cells, the action of PROK1 on migration of endometrial stromal cells, as well as migration and invasion of trophoblasts. We speculate that hyperinsulinaemia may be involved in the mechanisms by which PROK1 is linked to placenta-related pregnancy complications.

Indexed as

AdolescentAdultCell MovementCell SurvivalChoriocarcinomaDeciduaFemaleGastrointestinal HormonesHumansHypoxia-Inducible Factor 1, alpha SubunitInsulinPhosphatidylinositol 3-KinasesSignal TransductionSpheroids, CellularStromal CellsTrophoblastsGastrointestinal HormonesHIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitInsulinPhosphatidylinositol 3-KinasesPROK1 protein, humanVascular Endothelial Growth Factor, Endocrine-Gland-DeriveddecidualizationEG-VEGFendometriuminsulininvasionmigrationPROK1trophoblast

Identifiers

PMID28782224
PMCPMC5742737
OpenAlexW2744526267

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.